The release or activation of these growth factors enhances the expression of uPA, uPAR and PAI-1 components by paracrine, as well as other key processes in the development of cancer, such as angiogenesis and epithelial–mesenchymal transition [2,26]. The gene discussed is PLAU; the disease is cancer.